| Date Filed | Type | Description |
| 08/24/2023 |
SC 13D/A
| Juvenescence Ltd reports a 78.6% stake in AGEX THERAPEUTICS, INC. |
| 05/18/2023 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 756,429 options to buy
@ $0.661, valued at
$500k
|
|
| 03/22/2023 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Gifted 16,447,500 shares
@ $0 |
|
| 03/22/2023 |
SC 13D/A
| Juvenescence Ltd reports a 78.7% stake in AGEX THERAPEUTICS, INC. |
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
SC 13D/A
| Juvenescence Ltd reports a 72.6% stake in AGEX THERAPEUTICS, INC. |
| 12/19/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 847,457 options to buy
@ $0.59, valued at
$500k
|
|
| 12/15/2022 |
SC 13D/A
| Juvenescence Ltd reports a 74.9% stake in AGEX THERAPEUTICS, INC. |
| 10/27/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 362,318 options to buy
@ $0.69, valued at
$250k
|
|
| 10/25/2022 |
SC 13D/A
| Juvenescence Ltd reports a 73.4% stake in AGEX THERAPEUTICS, INC. |
| 08/24/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 746,380 options to buy
@ $0.6699, valued at
$500k
|
|
| 08/24/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 703,234 options to buy
@ $0.711, valued at
$500k
|
|
| 08/23/2022 |
SC 13D/A
| Juvenescence Ltd reports a 72.1% stake in AGEX THERAPEUTICS, INC. |
| 06/24/2022 |
SC 13D/A
| Juvenescence Ltd reports a 72.5% stake in AGEX THERAPEUTICS, INC. |
| 04/14/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 568,440 options to buy
@ $0.8796, valued at
$500k
|
|
| 04/11/2022 |
SC 13D/A
| Juvenescence Ltd reports a 68.1% stake in AGEX THERAPEUTICS, INC. |
| 03/11/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 5,230,768 options to buy
@ $0.78, valued at
$4.1M
|
|
| 02/22/2022 |
SC 13D/A
| Juvenescence Ltd reports a 69.5% stake in AGEX THERAPEUTICS, INC. |
| 02/14/2022 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Bought 308,565 options to buy
@ $0.8102, valued at
$250k
|
|
| 02/14/2022 |
SC 13D/A
| Juvenescence Ltd reports a 64.8% stake in AGEX THERAPEUTICS, INC. |
| 12/13/2021 |
SC 13D/A
| Juvenescence Ltd reports a 67.3% stake in AGEX THERAPEUTICS, INC. |
| 11/18/2021 |
SC 13D/A
| Juvenescence Ltd reports a 63% stake in AGEX THERAPEUTICS, INC. |
| 11/02/2021 |
SC 13D/A
| Juvenescence Ltd reports a 63% stake in AGEX THERAPEUTICS, INC. |
| 09/14/2021 |
SC 13D/A
| Juvenescence Ltd reports a 60.4% stake in AGEX THERAPEUTICS, INC. |
| 06/07/2021 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 05/26/2021 |
SC 13D/A
| Juvenescence Ltd reports a 57.2% stake in AGEX THERAPEUTICS, INC. |
| 05/11/2021 |
SC 13D/A
| Juvenescence Ltd reports a 56.1% stake in AGEX THERAPEUTICS, INC. |
| 04/08/2021 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 02/17/2021 |
SC 13D/A
| Juvenescence Ltd reports a 52.7% stake in AGEX THERAPEUTICS, INC. |
| 02/09/2021 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Bought 263,852 options to buy
@ $1.895, valued at
$500k
|
|
| 02/09/2021 |
SC 13D/A
| Juvenescence Ltd reports a 52.6% stake in AGEX THERAPEUTICS, INC. |
| 01/12/2021 |
4
| Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Bought 328,947 options to buy
@ $1.52, valued at
$500k
|
|
| 01/12/2021 |
SC 13D/A
| Juvenescence Ltd reports a 52.7% stake in AGEX THERAPEUTICS, INC. |
| 01/04/2021 |
D
| Form D - Notice of Exempt Offering of Securities: |
|